Table 4.
Biomarkers | Sub-Groups | Fetuin-A (ng/mL) | HOMA-IR | QUICKI | |||
---|---|---|---|---|---|---|---|
r | p value | r | p value | r | p value | ||
Cu2+ (μg/dL) | Diabetic Obese (DO) | 0.306 | 0.021* | 0.385 | 0.010* | −0.335 | 0.026* |
Diabetic Non-Obese (DNO) | −0.103 | 0.384 | −0.122 | 0.304 | 0.035 | 0.768 | |
Non-Diabetic. Obese (NDO) | −0.114 | 0.500 | −0.231 | 0.169 | 0.273 | 0.102 | |
Mn2+ (μg/L) | Diabetic Obese (DO) | 0.133 | 0.349 | −0.191 | 0.175 | 0.118 | 0.404 |
Diabetic Non-Obese (DNO) | −0.100 | 0.365 | −0.095 | 0.392 | 0.002 | 0.987 | |
Non-Diabetic Obese (NDO) | −0.262 | 0.082 | −0.113 | 0.084 | 0.084 | 0.584 | |
Mg2+ (mg/dL) | Diabetic Obese (DO) | 0.375 | 0.001* | 0.247 | 0.026* | −0.240 | 0.041* |
Diabetic Non-Obese (DNO) | 0.461 | 0.004* | 0.170 | 0.271 | −0.191 | 0.213 | |
Non-Diabetic Obese (NDO) | −0.248 | 0.052 | 0.045 | 0.789 | −0.068 | 0.688 | |
Fe2+ (μg/dl) | Diabetic Obese (DO) | −0.119 | 0.440 | −0.186 | 0.228 | 0.127 | 0.411 |
Diabetic Non-Obese (DNO) | −0.045 | 0.706 | −0.156 | 0.188 | 0.155 | 0.189 | |
Non-Diabetic Obese (NDO) | −0.168 | 0.321 | −0.186 | 0.270 | 0.254 | 0.129 | |
Se2+ (μg/L) | Diabetic Obese (DO) | −0.054 | 0.728 | −0.162 | 0.294 | 0.203 | 0.185 |
Diabetic Non-Obese (DNO) | 0.091 | 0.445 | −0.121 | 0.307 | 0.001 | 0.992 | |
Non-Diabetic Obese (NDO) | −0.116 | 0.495 | −0.226 | 0.179 | 0.133 | 0.434 | |
Cr2+ (μg/L) | Diabetic Obese (DO) | 0.062 | 0.688 | 0.236 | 0.123 | −0.191 | 0.214 |
Diabetic Non-Obese (DNO) | 0.068 | 0.565 | −0.152 | 0.199 | 0.200 | 0.090 | |
Non-Diabetic Obese (NDO) | 0.103 | 0.543 | −0.024 | 0.888 | −0.061 | 0.720 | |
Zn2+ (μg/dL) | Diabetic Obese (DO) | −0.004 | 0.979 | −0.152 | 0.326 | 0.185 | 0.229 |
Diabetic Non-Obese (DNO) | −0.067 | 0.571 | −0.121 | 0.310 | 0.015 | 0.900 | |
Non-Diabetic Obese (NDO) | −0.299 | 0.072 | −0.188 | 0.264 | 0.123 | 0.469 |
Abbreviations: r Pearson correlation coefficient. Pearson correlation was analyzed for correlation. *p value <0.05 is considered statistically significant